Compare BioNTech SE - ADR (BNTX) vs Diageo plc (DEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Diageo plc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Diageo plc trades at $94.63 (market cap $53.05B). The key difference: Diageo plc is far larger — about 2.3× BioNTech SE - ADR's market cap, and Diageo plc pays a 3.5% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | DEO | |
|---|---|---|
Market Cap | $23.31B | $53.05B |
Sector | Health | Technology |
52-Week High | $119.34 | $115.33 |
52-Week Low | $83.89 | $72.47 |
Enterprise Value | $6.60B | $72.54B |
Dividend Yield | — | 3.5% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →
